TAK-755 clinical trials

A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura

This study is looking at a new medicine called TAK-755 for people born with a rare blood clotting condition called TTP. It aims to see if TAK-755 can prevent or treat serious TTP flare-ups and check for any long-term side effects.